スライド 1 - ResearchGate

Development and Clinical
Evaluation of Rapid Diagnostic
Reagents for Measles
Kei Numazaki
International University of Health and Welfare
Takehiro Hasegawa, Takeshi Imoarai,
and Yukio Hamaguchi
Sysmex Corporation
Overview
Measles is a viral infectious disease caused by the measles virus, an enveloped
negative-strand RNA virus of the Morbillivirus genus in the Paramyxoviridae.
There is no specific treatment for measles and most people recover within 2–3 weeks.
However, particularly in malnourished children and people with lowered immunity,
measles can cause serious complications, including blindness, encephalitis, severe
diarrhea, ear infection and pneumonia.
Number of Reported Measles Cases with onset date from Dec 2010 to Jun 2011
(WHO measles Surveillance Data)
Despite the great effort, an increased number of outbreaks of measles in the African
and Western pacific regions were reported, and measles remains an important causes
of death.
Summary
□There is no clinically-useful rapid diagnosis for
measles over the world.
□Since atypical cases of measles are not uncommon,
rapid diagnosis based on laboratory testing is required.
□The purpose of this study is
to investigate the possibility of diagnosing measles
infection with a lateral flow-based rapid diagnostic kit
we developed.
The target antigen
for the lateral flow-based rapid diagnostic kit
In order to select the target protein for the lateral flow-based rapid diagnostic kit,
25 reagents were prepared with previously-developed antibodies for measles H, F, M
and N proteins, and the detection limits of them were examined using cultured virus of
Edmonston strain.
A.
B.
Rapid diagnostic kit for measles
Anti-measles monoclonal
antibody
Absorption
pad
H
Membrane
Latex
Membrane
Measles virus antigen
Evaluation of reactivity of kit with H,F,M or N proteins
B12
B5
B7
B12
B5
B7
C130
B12
B5
B7
C130
B12
B5
B7
C130
B12
B5
B7
C130
X1
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
X10
-
+
+
+
+
+
+
+
-
+
+
+
+
+
+
+
X100
ND
-
-
-
-
-
-
-
ND
-
+
-
-
+
-
-
X250
ND
ND ND
ND
ND
ND ND
ND
ND
ND
-
ND
ND
-
ND
ND
X500
ND
ND ND
ND
ND
ND ND
ND
ND
ND ND
ND
ND
ND ND
ND
X1,000
ND
ND ND
ND
ND
ND ND
ND
ND
ND ND
ND
ND
ND ND
ND
X2,000
ND
ND ND
ND
ND
ND ND
ND
ND
ND ND
ND
ND
ND ND
ND
F
Anti-measles monoclonal
antibody conjugated
color latex
Membrane
Sample pad Latex
Latex pad
C130
M
B48
C527
N
A23
A51
B4
B48
C527
B48
C527
A23
A51
A23
A51
B4
X1
+
+
+
+
+
+
+
-
+
X10
+
+
+
+
+
+
-
-
+
X100
-
-
+
-
-
-
-
ND
+
X250
ND
ND
-
ND
ND
ND
ND
ND
+
X500
ND
ND
ND
ND
ND
ND
ND
ND
+
X1,000
ND
ND
ND
ND
ND
ND
ND
ND
+
X2,000
ND
ND
ND
ND
ND
ND
ND
ND
-
Sample dilution rate is indicated at left. +, positive reaction; -, negative reaction: ND, not done.
B4 antibody to N protein exhibited 10 times higher sensitivity than the other antibodies.
Development of antibodies against recombinant
N proteins
Method of antibody production
Immunization of BALB/c mice with measles antigen
(antigen: measles virus-infected cell extract or recombinant N protein)
Fusion of a myeloma cell and the splenocyte from immunized mice
Cloning of the hybridoma producing antibodies with high reactivity
Incubation/antibody production in the abdominal cavity of mice
Purification
Reactivity of antibodies against recombinant N proteins
Latex
MV1-225
MV3-763
MV3-320
MV1-614
B4
MV-225
B4
MV2-3241
MV3-3892
MV1-1259
MV2-2214
MV3-1459
MV3-3892
MV2-3707
MV2-3241
MV3-3892
MV3-3892
MV2-1780
MV2-1780
MV2-1780
MV2-1780
MV2-1780
MV2-1780
MV2-2649
MV2-2649
MV2-2649
MV2-2649
H1
-
-
-
-
+
-
++
++
+
+
-
-
D3
++
++
++
+
++
+
++
++
++
++
++
-
D5
+
+
+
+
+
+
+
+
+
+
+
-
D9
+
+
-
-
-
+
+
+
+
+
+
-
A
+
+
+
+
-
-
++
+
+
+
+
-
Membrane
Genotype
MV1-1259
The reactivity of the lateral flow-based kit was examined with 1.6 ng/test recombinant N protein of H1, D3, D5, D9 and A genotypes.
Density of signal is indicated by ++, +: -, negative reaction.
Clone MV3-320, MV2-3707, MV2-2649 and MV2-3241 were selected for the antibodies of
the lateral flow-based kit.
The recognition site of antibodies against measles N
protein
The recognition site was examined using N protein deletion mutant.
A.
B.
Homology research for N protein of measles
virus antigen
C.
Immunocytochemistry for evaluation of reactivity
of antibodies
The scheme of deletion mutant of N protein
recognition site of antibody
The result of immunocytochemistry showed that the antibodies reacted to the highly
preserved region of the N protein.
The antibodies were thought to react measles N proteins of various genotypes.
The detection limits of the kits
The detection limits with two kits were evaluated with the Edmonston Schwarz FF-8
strain virus.
A.
Antibodies
kit-B
kit-A
Membrane MV2-3707 MV2-3241
MV2-2649 MV2-2649
Latex
MV3-320
B.
C.
The detection limits for
Edmonston Schwarz FF-8 strain
kit-A
kit-B
Schema of the lateral flow system
The detection limits were 5.1×103 copies/mL (kit-A) and 1.0×104 copies/mL (kit-B).
We chose kit-A as a rapid diagnostic kit for further evaluation.
Reactivity and cross-reactivity of the kit
Reactivity to wild type and recombinant antigens, and cross-reactivity to other
pathogen of both reagents were evaluated.
A.
C.
Reactivity to the wild type antigens
B.
Reactivity to the recombinant antigens
Detection limit
(Log PFU/test)
Kit
Detection limit
(ng/test)
Kit
Ys4(D5)
Ys1(H1)
IC-B(D3)
SA203(D5)
2.4
2.8
2.7
2.5
H1
D3
D5
D9
0.75
1.6
1.6
1.6
Cross-reactivity to other pathogens
Virus titer
Rubella
Mumps
RS
Adeno
Influenza A
Influenza B
1.5x104
1.5x103
1.2x103
5.7x104
9.6x105
1.4x106
TCID50/test
TCID50/test
PFU/test
TCID50/test
FFU/test
FFU/test
Kit
-
-
-
-
-
-
The kit reacted with wild type and recombinant antigens.
Cross-reactivity with other pathogens was not found.
Evaluation of the kit using clinical samples ①
《Protocol》
□Summary
■ Duration: March 2008 - July 2010
■ the number of facilities: 14
■ the number of patients: 45 (positive 11, negative 34)
■ Age:
0 - 38 years (Average 8.1 years)
■ Sex:
24 males, 20 females, 1 unknown
■ Reference assay: PCR analysis
□Method
■ In the collaboration facilities, throat samples of patients with suspected
measles infection were collected and diagnosed with the kit.
■ The residual samples for the kit were analyzed with PCR in the laboratory
Sampling and measurement of the kit
Collect throat
sample
Extract viral
antigen
Drop the sample
Insert the
assay strip
Detect (10 min)
Evaluation of the kit using clinical samples ②
We examined the correlation between the kit and PCR, and the symptoms in non-measles
patients.
A.
Correlation with PCR
PCR
+
Kit
+
-
-
5
6
Total
0 5
35 41
Total 11 35 46
Positive predictive value :45.5%
Negative predictive value :100%
B.
Clinical symptoms in non-measles patients
Clinical Symptoms
Fever Rash Cough
Number
of cases
35
25
6
Kit
Koplik Conjunctival
Nasal
spot
hyperemia discharge
21
12
12
Positive Negative
0
35
We confirmed that the kit could detect measles in clinical samples.
Although non-measles patients showed measles-like symptoms, the kit did not exhibit
false-positive.
Evaluation of the kit using clinical samples ③
A.
Clinical symptoms in measles patients
Clinical sy mptoms
1
2
3
4
5
6
7
8
9
10
11
B.
Age
Sex
TEMP
17.1
7.6
15.8
16
17.3
15.11
0.9
20
0.9
11.9
9.4
F
F
M
F
M
F
F
M
F
F
M
ND
38.6
ND
ND
ND
ND
ND
39.7
ND
39.1
39.4
Koplik
Fev er Rash
spot
+
+
+
+
+
+
+
+
+
+
+
+
+
+/+
+
+
+
+
+
+
+
+
+/+
+
+
+
+
Laboratory result
Nasal
Conjunctiv al
Ey e
Cough
Vaccination
discharge hy peremia discharge
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
1
ND
1
0
1
0
0
0
1
1
0
Day s af ter
onset of
f ev er
gene
ty pe
Log
copies/
test
0.5
0.75
2
3
3
4
4
4
4
6
7
D5
D5
D5
D5
D5
D5
D5
ND
ND
D5
D5
1.9
2.6
5.0
4.9
5.2
5.1
5.3
-0.4
3.5
3.8
2.6
kit-A
10min
20min
+
+
+
+
+
-
+
+
+
+
+
-
IgM
IgG
ND
5.7
3.1
5.7
9.6
23.1
1.6
9.7
24.5
25.0
24.8
ND
<2
96.6
2.1
3.1
<2
14.8
<2
5.1
12.3
The period of disease
6.0
Log copies/test
5.0
4.0
Result of the kit
●Positive
●Negative
3.0
2.0
1.0
The kit detected 71% (5/7) of measles cases at
2-4 day after onset of fever.
0.0
-1.0
0
2
catarrhal period
4
6
measles period
8
Result and Conclusion
Result
■ We developed the rapid diagnostic kit for measles
from throat swabs in 10 min.
■ Negative predictive value of the kit was 100% (35/35),
and positive predictive value was 45.5% (5/11).
■ The kit detected 71% (5/7) of measles cases at 2-4 day
after onset of fever.
■ Non-measles patients showed measles-like symptoms.
Conclusion
■ It is difficult to diagnose measles only based on clinical
symptoms.
■ The kit showed good specificity
■ The kit needs to be improved in sensitivity.